May 12, 2025: More Patients Sue Because of Side Effects of Ozempic and GLP-1 Products There are 1,809 lawsuits pending against the companies that made and sold Ozempic, the semaglutide medicine used to treat things like diabetes and obesity
This process strengthens tendons, ligaments, and joint structures by improving their structural integrity and flexibility
Sensoril is made from the leaves of Ashwagandha, giving it a unique chemical composition, which produces noticeable calming effects
Market impact and costs Global GLP-1 sales exceeded $41B in 2024 and are expected to triple by 2030, according to industry reports
Cardiovascular Benefits: Semaglutide stands out as it significantly reduces major adverse cardiovascular events (MACE) by 26% in patients with type 2 diabetes (SUSTAIN-6) 2 and is the only weight loss medication approved to lower the risk of major cardiovascular events, such as death, heart attack, or stroke, in adults with known heart disease and obesity or overweight (SELECT) 3